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ABSTRACT
Objectives: The prevalence of active tuberculosis (TB)
is low in Finland, but outbreaks do occur. Following
exposure national guidelines recommend either
tuberculosis skin test or interferon-γ-release assay-
testing of asymptomatic children. The aim of this study
was to compare QuantiFERON-TB Gold In-Tube test
(QFT) and interferon-γ-inducible protein (IP-10)
release assay for detection of Mycobacterium
tuberculosis infection following exposure to TB
in a primary school.
Design: A prospective cohort study.
Setting: School children in Helsinki, Finland.
Participants: Two siblings of the index case and
58 classmates exposed to M tuberculosis.
Intervention: All the children were screened using
the QFT, which was used to guide preventive treatment.
All those exposed were followed up through the
national TB registry.
Outcome measures: IP-10 was measured in plasma
supernatants from the QFT test supernatants and in
plasma dried and stored for 1 year on filter paper.
IP-10 test results were calculated using
preset algorithms for positive and indeterminate tests.
The negative predictive values of the tests were
assessed.
Results: At an initial screening 2 months after the
debut of symptoms in the index case, QFT was
positive in two children; 56 tests were negative;
one was indeterminate and one was borderline.
IP-10 showed a perfect concordance between the
dried plasma spot and plasma method; two children
were IP-10 positive and two were IP-10
indeterminate. There were two (3%) discordant
results between the QFT and IP-10 tests. Four
children converted to positive QFT at a 1–3 month
follow-up. None of the QFT negative/borderline
children developed TB in the 4-year period since
exposure.
Conclusions: We demonstrated that IP-10 and QFT
perform comparably as screening tools for infection
with M tuberculosis in a contact investigation. IP-10
determined in dried plasma spots was at par with
IP-10 determined in plasma, which further supports
the usefulness of this alternative approach.
INTRODUCTION
Tuberculosis (TB) remains a global epi-
demic. Childhood TB is a major cause of
childhood morbidity and mortality in
endemic regions. The diagnosis of TB in
children is difﬁcult owing to diverse clinical
presentations combined with paucibacillary
infection, making bacteriological conﬁrm-
ation challenging.1 Children infected with
Mycobacterium tuberculosis (latent TB infection
(LTBI)) are at a risk of developing TB;
wherefore, there is a great beneﬁt from
preventive therapy.2
Interferon-γ-release assays (IGRAs) and
interferon-γ-inducible protein (IP-10) release
ARTICLE SUMMARY
Article focus
▪ Interferon-γ and IP-10 release assays are tests
for detection of infection with Mycobacterium
tuberculosis, little is known about the perform-
ance of IP-10 release assays in contact tracing.
▪ We have recently developed a novel method for
IP-10 detection using dried plasma spots.
▪ In this study, we compare detection rates and
predictive values of IFN-γ and IP-10 release
assays in a primary school in Finland.
Key messages
▪ We demonstrated that IP-10 release assays and
the IFN-γ release assay (QuantiFERON-TB Gold
In-Tube) perform comparably as screening tools
in a contact tracing.
▪ IP-10 determined in dried plasma spots was at
par with IP-10 determined in plasma, which
further supports the utility of this alternative
technology.
Strengths and limitations of this study
▪ We have used a 4-year follow-up to substantiate
our findings.
▪ Our sample size is small but well characterised
and closely monitored.
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assays are immunological tests to identify infection
with M tuberculosis. IGRAs are commercially available as
the whole blood and ELISA-based QuantiFERON-TB
Gold In-Tube test (QFT) (QIAGEN, Valencia, USA), or
the PBMC and Eli-SPOT-based T-SPOT.TB test (Oxford
Immunotec, Abingdonm UK). IP-10 is a chemokine pro-
duced by monocytes following activation by antigen-
speciﬁc T cells recognising their speciﬁc peptide
presented on the monocyte surface. IP-10 is released in
100-fold higher concentrations compared to IFN-γ
making it feasible for detection with a lateral ﬂow, and
dried blood and dried plasma spot (DPS) technologies.3
A series of clinical studies suggest that IP-10 release
assays perform with a comparable sensitivity as IGRAs in
patients with a conﬁrmed TB and comparable speciﬁcity
in unexposed controls, and several studies have found
that IP-10 is less affected by low CD4 cell count in
HIV-infected individuals and by young age.3–5 Little is
yet known about the performance of IP-10 release assays
for the diagnosis of LTBI following a recent exposure to
M tuberculosis in a low-incidence country, nor the predict-
ive values for a positive or negative result.
In this study, we compared QFT to plasma and dried
plasma spot-based IP-10 release assays for the detection
of LTBI in children, following exposure to TB in a
school. We assessed the stability of DPS samples stored
for 1 year and determine the negative predictive values
(NPV) of the tests in a 4-year follow-up.
MATERIALS AND METHODS
Students and setting
The incidence of TB in Finland is low (6/100 000 inha-
bitants in 2010) with none to six active cases/year regis-
tered among children (<15 years) during the period
2000–2010.6
In March 2008, a schoolgirl of African background
started to cough, and in June, she was diagnosed with
sputum smear-positive TB. As a part of contact tracing
the classmates (close contact deﬁned as from 3 to 30 h/
week in the same classroom) and other close contacts
were examined for symptoms of active TB and investi-
gated with QFT ( June). Siblings were examined for
symptoms of active TB and QFT tested at the time of
diagnosis of the index case and 1 month later. For both
siblings and classmates, positive QFT tests were con-
ﬁrmed with the T-SPOT.TB test. Non-positive QFT tests
were repeated 3 months later (September). Four years
after the contact tracing, the progression rate in the chil-
dren was evaluated.
This study was approved by the Ethical Committee of
the Hospital for Children and Adolescents, University of
Helsinki (Nr.164/E7/05).
IFN-γ and IP-10 measurements
The modiﬁed version of QFT was performed according
to the standard operating procedure (SOP) adopted
in our laboratory (described in detail in refs.7 and 8).
In brief, stimulation of blood cells was done in tubes of the
manufacturer. However, for measurement of IFN-γ levels,
we used enzyme immunoassay (EIA) of PeliKine Compact
human EIA (Sanquin, Amsterdam, the Netherlands). This
results in a steeper calibration curve and a more accurate
result interpretation in the cutoff zone.7 Thereafter,
the excess supernatant from the QFT tubes was stored at
−80°C and later shipped on dry ice to the research labora-
tory at the Copenhagen University Hospital, Hvidovre,
Denmark. In August 2010, the samples were thawed and
2×25 µl from each sample was pipetted onto Whatman
903 ﬁlter paper (Whatman, Maidstone, UK), dried for 4 h
and stored at −20°C for a later analysis; plasma samples
were refrozen and stored at −80°C. In February 2012,
plasma and dried plasma spot samples were analysed for
IP-10 using an in-house IP-10 ELISA.9
IFN-γ and IP-10 test interpretations
IFN-γ and IP-10 concentrations were analysed according
to previously set algorithms. For IFN-γ, two cutoff levels
were applied: Samples showing a net reactivity (the
reactivity of a sample minus the reactivity of the nil
control) <0.35 IU/ml were interpreted as negative.
Those showing reactivity between 0.35 and 0.50 IU/ml
were interpreted as being borderline and those with a
reactivity exceeding 0.50 IU/ml were interpreted as posi-
tive. The IP-10 test was considered positive if net reactiv-
ity was above 2.3 ng/ml (plasma) and 125 pg/2 DPS
discs and deemed indeterminate if the test was negative
and a net reactivity of the positive control was below
1.5 ng (plasma) and 71 pg/2 DPS discs.10
Statistics
Biomarker concentrations were compared using non-
parametric statistics. Test results were compared using
the McNemars test and κ statistics. Correlation was
assessed using the Persons method. Data were analysed
using the GraphPad Prizm V.5.0 for Mac and SAS V.9.3.
RESULTS
Children, setting and QFT results
A total of 67 children were included in the contact inves-
tigation; 58 classmates from the school, 7 other close
contacts and 2 siblings to the index case (ﬁgure 1).
Among these seven other close contacts, three had posi-
tive QFT and tuberculosis skin test (TST), which were
regarded LTBI. These seven samples were not available
for IP-10 analysis and they were excluded. A total of 60
individuals were included in the study.
The index case has two siblings. Both were clinically
examined and QFT screened at the time of diagnosis of
the index case and 1 month later. The sister (age 13) had
symptomatic disease at the initial screening in June and
received full TB treatment. Her QFT converted from 0
( June) to 18.34 IU/ml ( July). The brother (age 9) was
asymptomatic, but received LTBI treatment based on a
QFT conversion from 0.0 ( June) to 20.4 UI/ml (August).
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The 58 school children had a median age of 12 years
(range 11–14), 40% (25/58) being male. One child had
a missing mitogen sample and was classiﬁed as a deter-
minate (valid test). At the initial screening ( June), the
QFT test identiﬁed 1 positive, 1 borderline, 55 negative
and 1 indeterminate cases. At a retest, 3 months later
two children had converted from no reaction (0.00 and
0.02 IU/ml) to strong positive results (6.24 and
10.21 IU/ml IFN-γ). All children with positive tests
received LTBI treatment.
IP-10 and IFN-γ levels
Nil and antigen samples from the initial screening were
available for 58 school children and 1 sibling. The
sibling with symptomatic disease was retested 3 weeks
after the treatment was started. This sample was available
for the study. Raw values for each biomarker are pre-
sented in table 1. Correlation between nil, antigen and
mitogen samples pooled (n=179) was very high for IP-10
(r2=0.98 for IP-10 plasma vs DPS, p<0.0001) and high
for IFN-γ vs IP-10 (r2=0.69 and 0.68 for IP-10 plasma and
DPS, respectively, p<0.0001, data not shown).
IP-10 test results and concordance
The two IP-10 tests had a perfect agreement (60/60,
k=1.00, p<0.0001) rendering 2 positive, 56 negative and
2 indeterminate (see table 2). The two children who
converted to positive QFT at 3 months rescreening were
both IP-10 unresponsive at the initial screening. The
agreement between QFT and either of the IP-10 tests
was 97%, (58/60, k=0.86, p<0.0001 (borderline classiﬁed
as negative)). Two children were concordant QFT/IP-10
positive. Both were also positive on T-SPOT.TB used as a
conﬁrmatory method.
There were two discordant results. One Finnish-born girl
had QFT borderline results (0.45 IU/ml IFN-γ); it is note-
worthy that she also had the highest spontaneous IFN-γ
production in the cohort (0.83 IU/ml). This girl had IP-10
levels of 1.26 ng/ml and 26 pg/2 DPS spots (plasma and
DPS samples, respectively, which is interpreted as IP-10-test
negative; ﬁgure 2A). She was further tested with T-SPOT.
Table 1 IFN-γ and IP-10 levels in plasma and dried plasma spots
Nil Antigen Mitogen
IFN-γ (IU/ml) 0.04 (0.02–0.11) 0.04 (0.02–0.12) 9.57 (5.52–10.00)
IP-10 plasma (ng/ml) 0.16 (0.05–0.44) 0.27 (0.10–0.53) 9.80 (4.84–13.19)
IP-10 DPS (pg/2 DPS discs) 4.2 (0.00–14.3) 3.3 (0.00–14.6) 280.9 (148.1–381.2)
DPS, dried plasma spot; IP-10, interferon-γ-inducible protein.
Figure 1 Schematic overview of the contact tracing. Sixty-seven contacts were screened, of which 60 had samples available for
the study. Samples from the initial screening (white bar in the middle) were used in the study. *Siblings were screened once
before the samples included in this study were obtained. At that time, both tests were negative (see the main text). These
samples were not available for the study.
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TB and tuberculin skin test, both tests being negative. This
child was not offered any treatment.
Another child was IP-10 indeterminate but QFT nega-
tive. IFN-γ levels in response to mitogen were 1.4 IU/ml,
and IP-10 levels were 1.27 ng/ml and 43 pg/2 DPS discs,
in plasma and DPS samples, respectively (ﬁgure 2B).
Follow-up
No new cases were found among the contacts during
the following 4 years; the total follow-up time of this
study has been 240 person years. None of the seven con-
tacts with a positive test and no symptoms of active TB
(four contacts included in the study and the three other
close contacts) had recurrent TB.
DISCUSSION
In this study, we compared the QFT and the IP-10 tests
for the diagnosis of LTBI in a cohort of 6th grade school
children from an urban setting in Finland. IP-10 was
detected in both plasma samples and dried plasma spots
and analysed using pre-set test algorithms; the two IP-10
methods were 100% concordant. Two children were
deemed IP-10 and QFT positive. The QFT test showed
97% agreement with both the IP-10 tests. The children
were followed up for 4 years and no new cases were iden-
tiﬁed, rendering a very high negative predictive value for
both QFT and IP-10 tests.
This is the ﬁrst study to describe the performance of
IP-10 in a contact-tracing investigation in school children
in a low-endemic setting. We applied IP-10 cutoffs and
test algorithms for plasma and DPS estimated in cohorts
of cases with active TB and healthy controls.10 As
expected, IP-10 from dried plasma spots and plasma
samples correlated well, and a good agreement between
the test results was obtained.9 10 The DPS samples had
been stored in sealed plastic bags with a desiccant for
12 months at −20°C before analysis, apparently without
a loss of IP-10 signal. This ﬁnding adds to previous
experiments of IP-10 stability in dried form on ﬁlter
paper, where it was shown that there was no loss of IP-10
signal after 4 weeks of storage at temperatures up to
+37°C.9
IP-10 and QFT performed similar, albeit 2 of the 60
paired samples were discordant. These ﬁndings are in
line with previous studies in adults and children without
any active TB or comorbidity.11–15 One child was QFT
borderline/IP-10 negative; this 12-year-old girl was TST
and T-SPOT.TB negative at both initial and repeat tests
3 months later. Based on the complete test panel, no
treatment was initiated. This child remains asymptom-
atic. Most probably, this child was not infected and the
QFT was false positive, if the interpretation for positivity
is taken strictly as instructed. We and others have shown
earlier that the QFT assay could have high variation
around the cutoff area, thus cautioning not to
misinterpret clinical conversions and reversions when
sequential samples are analysed.16–18 IP-10 is expressed in
100-fold higher levels making detection of low-level
responses possible with a simpler technology such as
the ﬁlter paper assay, but also with a higher accuracy
Figure 2 Correlation plots: (A)
Antigen-specific IFN-γ vs IP-10
(plasma) release, Lines denotes
cutoff for the borderline
0.35–0.50 IU/ml and positive test
0.50 IU/ml and 2.3 ng/ml for IFN-γ
and IP-10, respectively. (B)
Mitogen-specific IFN-γ vs IP-10
(plasma) release lines denote
cutoffs for indeterminate tests
0.5 IU/ml and 1.5 ng/ml for IFN-γ
and IP-10, respectively. Arrows
denote discordant responders.
Table 2 Test concordance
IP-10 (plasma or dried plasma spots)
Positive Negative Indeterminate
QFT Positive 2 0 0 2
Borderline 0 1 0 1
Negative 0 55 1 56
Indeterminate 0 0 1 1
2 56 2 60
IP-10, interferon-γ-inducible protein; QFT, QuantiFERON-TB Gold In-Tube test.
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compared to IFN-γ.3 9 Further studies are needed to
compare the reproducibility of the IP-10 and QFT ELISAs
at concentrations in the range of the diagnostic cutoff.
Another discordant result was in a child who had a
negative QFT and an indeterminate IP-10 test result.
The IP-10 response to mitogen was only 0.23 ng/ml
below the cutoff for an indeterminate test.10 Notably, the
current cutoff for indeterminate tests was established on
a small set of data, and a larger material is needed to val-
idate this cutoff.
Predictive value
One of the key questions in the ﬁeld is how well IGRAs
differentiate between people who will develop TB and
those who will not, that is, the ‘predictive value’ of the
IGRAs. In this study, none of the 56 children with nega-
tive QFT and IP-10 progressed to active TB at a 4 years
follow-up, rendering a NPV of 100%. To our knowledge,
this is the ﬁrst assessment of the negative predictive
value of IP-10. This ﬁnding supports recent reports dem-
onstrating a very high negative predictive value of the
IFN-γ-based IGRAs (reviewed by Diel et al19).
LIMITATIONS
There is no gold standard for M tuberculosis infection
wherefore our assessments of QFT and IP-10 detection
rates might be imprecise. Studies in patients with active
TB suggest that both tests do not have perfect sensitivity
and there is a risk of underestimation of the number of
truly infected children.3 20 The long follow-up period
brings strength to the assessment of the predictive
values, but the low number of observations increases the
risk of type-2 error. IFN-γ was measured using the SOP
developed as HUSLAB. This method ensures a higher
degree of accuracy in the IFN-γ measurements and
has been fully optimised for the QFT interpretation
algorithm.7 17 This modiﬁed algorithm classiﬁes responses
between 0.35 and 0.50 as borderline responses. One child
fell into this category, and was subjected to further testing
with the T-SPOT.TB and TST. Both these tests as well as the
IP-10 test were found to be negative. This ﬁnding under-
lines the importance of interpreting IGRA responses based
on both the test result per se and importantly also on the
basis of the biomarker concentration.
CONCLUSION
We demonstrated that IP-10 and QFT perform compar-
ably as screening tools for infection with M tuberculosis in
a contact tracing. Both tests demonstrated 100% NPV.
IP-10 determined in dried plasma spots was at par with
IP-10 determined in plasma, which further supports the
utility of this alternative technology.
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